Pursley James 4

What Happened

• James Pursley, President of Hinge Health (HNGE), sold a total of 15,000 shares in three open-market transactions on 2026-03-23, generating aggregate proceeds of $633,928. The individual sales were 2,256 shares at $41.21 ($92,976); 9,838 shares at $42.36 ($416,709); and 2,906 shares at $42.75 ($124,243). These transactions are sales (S), not purchases.

Key Details

• Transaction date: 2026-03-23; Form 4 filed: 2026-03-24 (appears timely).
• Per-line prices and proceeds:
  • 2,256 shares @ $41.21 = $92,976 (footnote F2: weighted avg; prices ranged $40.66–$41.62).
  • 9,838 shares @ $42.36 = $416,709 (footnote F3: weighted avg; prices ranged $41.66–$42.65).
  • 2,906 shares @ $42.75 = $124,243 (footnote F4: weighted avg; prices ranged $42.66–$42.86).
• Combined weighted average price ≈ $42.26 per share; total proceeds $633,928.
• Shares owned after the transaction: not specified in this Form 4.
• Notable footnote: F1 states these sales were effected pursuant to a Rule 10b5-1 trading plan adopted June 13, 2025 — indicating the trades were made under a pre-established plan. Footnotes F2–F4 note weighted-average pricing and provide price ranges; the filer offers to provide exact per-price sale counts on request.

Context

• These are outright sales (not option exercises or awards). Because they were executed under a 10b5-1 plan, the trades were likely pre-scheduled; this reduces (but does not eliminate) inference about timing or insider intent. For retail investors, purchases generally carry stronger signals than routine sales; this filing documents routine liquidity under a trading plan rather than an acquisition.